Adrenocortical oncocytic neoplasm presenting with Cushing's syndrome: a case report

<p>Abstract</p> <p>Introduction</p> <p>Oncocytic neoplasms occur in several organs and are most commonly found in the thyroid, kidneys and salivary glands. Oncocytic neoplasms of the adrenal cortex are extremely rare and are usually non-functioning.</p> <p>Case presentation</p> <p>We report the case of an adrenocortical oncocytic neoplasm with uncertain malignant potential in a 31-year-old man with Cushing's syndrome. The patient had been operated on following diagnosis of a 7 cm adrenal mass. Following surgery, the Cushing's syndrome resolved. The patient is still alive with no metastases one year after the surgery.</p> <p>Conclusion</p> <p>Adrenocortical oncocytic neoplasms must be considered in the differential diagnosis of both functioning and non-functioning adrenal masses.</p

Early and Late Complications of Urinary Diversions after Radical Cystectomy

One of the strongest predictive factors for the early and late postoperative complications and morbidity of radical cystectomy is the type of urinary diversion following cystectomy. In this paper, we reviewed English-language literature on urinary diversions after cystectomy and their early and late complications. All types of urinary diversions have potential risks of diversion-related metabolic complications, infection, intestinal obstruction and renal deficiency. Although there is no agreement on the ideal urinary diversion, orthotopic neobladder without an external stoma is the most popular type of diversion in appropriate patients due to the protection of body image. Ileal conduit is another frequently selected urinary diversion for elderly patients with comorbidity. Both orthotopic neobladder and ileal conduits are well tolerated options with low morbidity. Nevertheless, postoperative early and late complications, such as urinary tract infections, pyelonephritis, urinary leakage, stomal stenosis, urolithiasis and morphological changes in the upper urinary tract should be kept in mind

Perineal Ectopic Testis: A Rare Congenital Anomally

Perineal ectopic testis is a rare congenital anomally. The incidence of perineal ectopic testis is less than 1% in all undescended testis. Patient usually applied to urology with empty scrotum and testicular agenesia. The main treatment is surgical and hormonal therapy is not indicated in these patients. We report an eleven years old patient with right perineal ectopic testis that was underwent scrotal orchidopexy [Cukurova Med J 2013; 38(1.000): 138-141

The Optimum Dosage of Prilocaine in Periprostatic Nerve Block During Transrectal Ultrasound Guided Prostate Biopsy: A New Approach in Dose Calculation

Objective: We aimed to calculate the optimum dose of prilocaine per one mL prostate volume in periprostatic nerve block (PPNB) during transrectal ultrasound (TRUS) guided prostate biopsy (PBx). Materials and Methods: We retrospectively evaluated the medical records of 83 patients from whom 12 cores TRUS guided PBx were obtained between years 2011 and 2013. Prostatic sizes were evaluated separately as Size 1 (anterior-posterior on the axial plane), Size 2 (transversal), and Size 3 (cranial-caudal on the sagittal plane) for all patients. The visual analog scores (VAS) of the patients during PBx, prostatic volumes, and prilocaine doses per one mL prostate were evaluated. The correlation between VAS of patients during PBx and prostatic volume, the prostatic sizes and prilocaine dosage per one mL prostate was analyzed using Cubic regression test. Results: It was found that VAS scores of patients were significantly positive correlated with prostatic volume, Size 1, 2 and 3 (p<0.05). However, there was a negative significant correlation between VAS and prilocaine dose per one mL prostate volume (r=-0.402, p<0.01). The dose of 0.1 mL prilocaine infiltration per one mL prostatic tissue in PPNB was the maximum dose that caused a mild and under annoying pain (VAS<2) in patients according to cubic regression formula. Conclusion: Prilocaine dosage, prostatic volume and prostatic sizes (especially anterior-posterior and cranial-caudal) significantly affect VAS scores during TRUS guided PBx. The pain in TRUS guided PBx should be controlled with an optimum dose of prilocaine as 0.1 mL per one mL of prostatic tissue